Back
HFA Premium Access

Have we found the Holy Grail in Heart failure with reduced ejection fraction? - First experiences with sacubitril/valsartan among heart transplant candidates

Session: Poster Session 1 - Clinical Cases
Topic: Pharmacotherapy
Speaker: Doctor B. Muk (Budapest, HU)
Event: Heart Failure 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Balazs Muk

Gottsegen National Cardiovascular Center, Budapest (Hungary)
2 presentations
0 follower

28 more presentations in this session

A rare case of atrial septal defect with mitral valve papillary fibroelastoma

Speaker: Mr A. Filias (Patras, GR)

Access
Abstract
Like
Thumbnail

Belated diagnosis of non-ischemic dilated cardiomyopathy in a patient with previous bypass surgery

Speaker: Doctor M. Bazmpani (Thessaloniki, GR)

Access
Abstract
Like
Thumbnail

Successful percutaneous transcatheter closure of a prosthetic mitral paravalvular leak causing heart failure

Speaker: Associate Professor T. Habon (Pecs, HU)

Access
Abstract
Like
Thumbnail

Significant reduction of insulin dose after administration of sacubitril/valsartan in the patient with heart failure due to dilated cardiomyopathy, a case report.

Speaker: Doctor M. Hegarova (Prague, CZ)

Access
Abstract
Slides
Like
Thumbnail

Reversible left bundle branch block after sacubitril/valsartan in patient with severe heart failure

Speaker: Doctor P. Lin (Hsinchu, TW)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 1 - Clinical Cases

Speakers: Doctor B. Muk, Mr A. Filias, Doctor M. Bazmpani, Associate Professor T. Habon, Doctor M. Hegarova...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources